Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy
- PMID: 19448435
- DOI: 10.4161/cc.8.11.8544
Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy
Abstract
Here, we discuss recent evidence that an absence of stromal Cav-1 expression in human breast cancers is a powerful single independent predictor of early disease recurrence, metastasis and poor clinical outcome. These findings have now been validated in two independent patient populations. Importantly, the predictive value of stromal Cav-1 is independent of epithelial marker status, making stromal Cav-1 a new "universal" or "widely-applicable" breast cancer prognostic marker. We propose based on the expression of stromal Cav-1, that breast cancer patients could be stratified into high-risk and low-risk groups. High-risk patients showing an absence of stromal Cav-1 should be offered more aggressive therapies, such as anti-angiogenic approaches, in addition to the standard therapy regimens. Mechanistically, loss of stromal Cav-1 is a surrogate biomarker for increased cell cycle progression, growth factor secretion, "stemness", and angiogenic potential in the tumor microenvironment. Since almost all cancers develop within the context of a stromal microenvironment, this new stromal classification system may be broadly applicable to other epithelial and non-epithelial cancer subtypes, as well as "pre-malignant" lesions (carcinoma in situ).
Similar articles
-
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.Cell Cycle. 2010 Jun 15;9(12):2412-22. doi: 10.4161/cc.9.12.11989. Epub 2010 Jun 15. Cell Cycle. 2010. PMID: 20562527
-
Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.Pathol Oncol Res. 2012 Apr;18(2):459-69. doi: 10.1007/s12253-011-9469-5. Epub 2011 Nov 7. Pathol Oncol Res. 2012. PMID: 22057638
-
Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.Ann Surg Oncol. 2014 Jan;21(1):329-36. doi: 10.1245/s10434-013-3225-x. Epub 2013 Aug 28. Ann Surg Oncol. 2014. PMID: 23982252
-
Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.Semin Oncol. 2014 Apr;41(2):195-216. doi: 10.1053/j.seminoncol.2014.03.002. Epub 2014 Mar 5. Semin Oncol. 2014. PMID: 24787293 Review.
-
Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.Breast Cancer Res. 2011 Jul 8;13(4):213. doi: 10.1186/bcr2892. Breast Cancer Res. 2011. PMID: 21867571 Free PMC article. Review.
Cited by
-
Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer.Int J Mol Sci. 2012 Oct 24;13(11):13764-80. doi: 10.3390/ijms131113764. Int J Mol Sci. 2012. PMID: 23203033 Free PMC article.
-
Caveolin-1 expression is elevated in claudin-low mammary tumor cells.Cancer Cell Int. 2012 Feb 22;12:6. doi: 10.1186/1475-2867-12-6. Cancer Cell Int. 2012. PMID: 22356861 Free PMC article.
-
Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells.Cell Cycle. 2011 Aug 1;10(15):2521-8. doi: 10.4161/cc.10.15.16584. Epub 2011 Aug 1. Cell Cycle. 2011. PMID: 21768775 Free PMC article.
-
The impact of caveolin protein expression in tumor stroma on prognosis of breast cancer.Tumour Biol. 2011 Aug;32(4):787-99. doi: 10.1007/s13277-011-0181-6. Epub 2011 May 17. Tumour Biol. 2011. PMID: 21584795
-
Future directions in the field of endometrial cancer research: the need to investigate the tumor microenvironment.Eur J Gynaecol Oncol. 2010;31(2):139-44. Eur J Gynaecol Oncol. 2010. PMID: 20527227 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical